Table 1.

Correlations between expressions of SHH and GLI1 protein and clinicopathological factors

	SHH expression				GLI1 expression
Clinical parameters	Low (n = 37)	High (n = 53)	χ2	p	Low (n = 50)	High (n = 40)	χ2	p
Gender
Male	20	33	0.607	0.436	24	29	5.510	0.019*
Female	17	20			26	11
Age
< 60 years	13	22	0.373	0.542	15	20	3.740	0.053
≥ 60 years	24	31			35	20
Tumor size
< 5.0 cm	14	21	0.029	0.864	21	14	0.458	0.498
≥ 5.0 cm	23	32			29	26
Tumor Location
Fundus	5	6	0.241	0.886	6	5	0.477	0.788
Body	15	20			21	14
Antrum	17	27			23	21
Invasion depth
T1,T2	4	10	1.077	0.383	11	3	3.557	0.080
T3,T4	33	43			39	37
LNM
Negative	11	12	0.575	0.448	13	10	0.012	0.914
Positive	26	41			37	30
Metastasis
Absent	35	51	0.137	1.000	48	38	0.052	1.000
Positive	2	2			2	2
Vessel invasion
Negative	28	33	1.795	0.180	36	25	0.918	0.338
Positive	9	20			14	15
TNM stage
I, II	14	26	1.111	0.292	21	19	0.272	0.602
III, IV	23	27			29	21

TNM Tumor, node, metastasis, LNM Lymph node metastasis

^*Significant difference